Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT02223338Completed
Open-label trial of ciprofloxacin + ibuprofen gel in endophthalmitis (2 arms), sponsored by Loma Linda University. Primary endpoint: Number of Participants With Resistance of Ocular Flora to Commonly Used Post-injection Prophylactic Antibiotics at 7 days. Started Oct 2014; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT02223338.